SCHEMBL29965337

SCHEMBL29965337

COc1ccc(CSc2cc(O)ncc2OCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.49
CYP2E1 P05181 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C8 P10632 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2B6 P20813 1/20 0.47
CYP2C19 P33261 1/20 0.47
PPARG P37231 2/20 0.44
PPARD Q03181 2/20 0.44
PPARA Q07869 2/20 0.44
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 1/20 0.43
NOD2 Q9HC29 1/20 0.43
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663276 1.00 ABCB1 (0.49) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL29965423 0.86 ABCB1 (0.49) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL23663289 0.86 ABCB1 (0.49) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL23663372 0.81 LMNA (0.42) CYP2C19MAPTMAPK1NPC1RAB9A
SCHEMBL23691246 0.79 LMNA (0.50) CYP2C9CYP2C19MAPTMAPK1GSK3B
SCHEMBL23663373 0.78 ABCB1 (0.47) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL23663294 0.77 CYP2C9 (0.40) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL23663296 0.77 ABCB1 (0.40) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL23663321 0.77 ABCB1 (0.40) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL29965617 0.77 ABCB1 (0.40) ABCB1CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF ECCOGENE INC (US) 2025-10-16 US disclosed
CN-115244037-B Substituted triazinones as thyroid hormone receptor agonists 诚益生物(美国)公司 2024-10-25 CN disclosed
EP-4090652-A1 SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS Eccogene (Shanghai) Co., Ltd. (CN) 2022-11-23 EP disclosed
CN-115244037-A Substituted triazinones as thyroid hormone receptor agonists 上海诚益生物科技有限公司 2022-10-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF TSHR, THRA, THRB ABCB1 2159/4885CYP2E1 1671/4885CYP3A4 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.